Haematologic indices in hepatitis B virus-related liver disease

Clin Chim Acta. 2020 Jan:500:135-142. doi: 10.1016/j.cca.2019.10.007. Epub 2019 Oct 23.

Abstract

Several markers and prognostic scores have been identified for predicting the development and progression of liver disease; among them, haematological parameters (the neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), platelet to lymphocyte ratio (PLR), red cell distribution width (RDW), RDW to platelet ratio (RPR), mean platelet volume (MPV), and mean corpuscular volume (MCV)) have recently gained significant interest. Compared with traditional prognostic factors, haematological indices are easy to obtain and relatively inexpensive. There is growing evidence that these haematological indices play a key role in HBV-related liver diseases and has been proposed as a predictive marker of adverse outcomes in these patients. This article focuses on discussing the diagnostic and prognostic value of the haematological indices in patients with HBV-related liver diseases.

Keywords: Diagnosis; Haematological indices; Hepatitis B virus; Prognosis; Systematic review.

Publication types

  • Review

MeSH terms

  • Hematologic Tests*
  • Hepatitis B virus / physiology*
  • Humans
  • Liver Diseases / blood*
  • Liver Diseases / virology*